The prognostic significance of LncRNA BLACAT1 overexpression in various tumors: a meta-analysis
- PMID: 38601076
- PMCID: PMC11004358
- DOI: 10.3389/fgene.2024.1362420
The prognostic significance of LncRNA BLACAT1 overexpression in various tumors: a meta-analysis
Abstract
Objective: Recent studies have revealed increasing evidence that the long non-coding RNA bladder cancer associated transcript 1 (LncRNA BLACAT1) plays an essential role in the emergence of different malignancies. This meta-analysis aimed to evaluate the prognostic significance of LncRNA BLACAT1 in various cancers.
Methods: Six electronic databases (PubMed, Embase, Medline, Web of Science, China National Knowledge Infrastructure (CNKI), and the Chinese WanFang database) were comprehensively searched for relevant studies. The analysis of overall survival (OS) and clinicopathological characteristics was conducted.
Results: Nineteen studies with 1,559 patients were eventually eligible to be included in this meta-analysis. High expression level of LncRNA BLACAT1 was identified to be linked with shorter OS (HR: 2.02, 95% CI: 1.66-2.46, p < 0.001) and PFS (HR: 2.424, 95% CI: 1.827-3.020, p < 0.001) in cancer patients as opposed to low expression levels. Subgroup analysis showed that analysis model (multivariate or univariate), cut-off value (mean or median), sample size (more or fewer than 100), and cancer type had little effect on OS in multiple tumors. Moreover, high LncRNA BLACAT1 expression was associated with positive lymph node metastasis (HR: 2.29, 95% CI: 1.66-3.16, p < 0.00001), advanced clinical stage (HR: 2.29, 95% CI: 1.65-3.19, p < 0.00001) and worse differentiation status (HR: 0.58, 95% CI: 0.37-0.92, p = 0.02), compared to low LncRNA BLACAT1 expression.
Conclusion: The findings highlight that high LncRNA BLACAT1 expression might be detrimental and induce a worse prognosis for cancer patients.
Keywords: cancer; long non-coding RNA BLACAT1; meta-analysis; prognosis; survival.
Copyright © 2024 Yan, Zhang, Wang and Wang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Prognostic and Clinicopathological Significance of Long Non-Coding RNA BLACAT1 in Cancer: An Updated Meta-Analysis and TCGA Data Review.Clin Lab. 2020 Nov 1;66(11). doi: 10.7754/Clin.Lab.2020.200310. Clin Lab. 2020. PMID: 33180447
-
LncRNA BLACAT1 May Serve as a Prognostic Predictor in Cancer: Evidence from a Meta-Analysis.Biomed Res Int. 2019 Apr 2;2019:1275491. doi: 10.1155/2019/1275491. eCollection 2019. Biomed Res Int. 2019. PMID: 31061820 Free PMC article. Review.
-
Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.PLoS One. 2020 Oct 14;15(10):e0240321. doi: 10.1371/journal.pone.0240321. eCollection 2020. PLoS One. 2020. PMID: 33052949 Free PMC article.
-
Prognostic and Clinicopathological Significance of lncRNA MVIH in Cancer Patients.J Cancer. 2019 Feb 26;10(6):1503-1510. doi: 10.7150/jca.28541. eCollection 2019. J Cancer. 2019. PMID: 31031860 Free PMC article.
-
The prognostic value of high LncRNA AFAP1-AS1 expression in various cancers: A systematic review and meta-analysis containing 21 studies.Clin Chim Acta. 2018 Jun;481:147-153. doi: 10.1016/j.cca.2018.03.006. Epub 2018 Mar 12. Clin Chim Acta. 2018. PMID: 29544748 Review.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources